Similar articles for PMID: 26182255

Year	Number of Results
1989	1
1995	1
1997	1
2000	2
2001	1
2002	1
2005	2
2006	1
2008	2
2009	3
2010	7
2011	2
2012	4
2013	14
2014	29
2015	22
2016	21
2017	20
2018	16
2019	13
2020	8
2021	11
2022	4
2023	1
2024	0

1

[Hepatocellular Carcinoma: therapeutic options 2015].

Schultheiß M, Bettinger D, Neeff HP, Brunner TB, Thimme R. Schultheiß M, et al. Dtsch Med Wochenschr. 2015 Jul;140(14):1063-8. doi: 10.1055/s-0041-102333. Epub 2015 Jul 16. Dtsch Med Wochenschr. 2015. PMID: 26182255 German.

2

Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.

Eggert T, Greten TF. Eggert T, et al. Digestion. 2017;96(1):1-4. doi: 10.1159/000464282. Epub 2017 Jun 13. Digestion. 2017. PMID: 28605745 Free PMC article. Review.

3

Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study.

Liu F, Meng Z, Shao G, Wang J, Wang Z, Yang J, Yip CS, He D. Liu F, et al. Mol Biol Rep. 2017 Feb;44(1):149-158. doi: 10.1007/s11033-016-4092-x. Epub 2016 Dec 15. Mol Biol Rep. 2017. PMID: 27981445

4

Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.

Bettinger D, Spode R, Glaser N, Buettner N, Boettler T, Neumann-Haefelin C, Brunner TB, Gkika E, Maruschke L, Thimme R, Schultheiss M. Bettinger D, et al. BMC Gastroenterol. 2017 Aug 10;17(1):98. doi: 10.1186/s12876-017-0656-z. BMC Gastroenterol. 2017. PMID: 28797231 Free PMC article.

5

Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.

Zhang Y, Fan W, Wang Y, Lu L, Fu S, Yang J, Huang Y, Yao W, Li J. Zhang Y, et al. Oncologist. 2015 Dec;20(12):1417-24. doi: 10.1634/theoncologist.2015-0196. Epub 2015 Oct 7. Oncologist. 2015. PMID: 26446238 Free PMC article. Clinical Trial.

6

Treatment of hepatocellular carcinoma: beyond international guidelines.

Colombo M, Sangiovanni A. Colombo M, et al. Liver Int. 2015 Jan;35 Suppl 1:129-38. doi: 10.1111/liv.12713. Liver Int. 2015. PMID: 25529098 Review.

7

Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.

Gandhi M, Choo SP, Thng CH, Tan SB, Low AS, Cheow PC, Goh AS, Tay KH, Lo RH, Goh BK, Wong JS, Ng DC, Soo KC, Liew WM, Chow PK; Asia-Pacific Hepatocellular Carcinoma Trials Group. Gandhi M, et al. BMC Cancer. 2016 Nov 7;16(1):856. doi: 10.1186/s12885-016-2868-y. BMC Cancer. 2016. PMID: 27821083 Free PMC article. Clinical Trial.

8

Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.

Geschwind JF, Chapiro J. Geschwind JF, et al. Clin Adv Hematol Oncol. 2016 Aug;14(8):585-7. Clin Adv Hematol Oncol. 2016. PMID: 27487101 No abstract available.

9

Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis .

Huang Y, Chen B, Liu N, Li N, Dao H, Chen W, Yang J. Huang Y, et al. Int J Clin Pharmacol Ther. 2017 Jun;55(6):498-508. doi: 10.5414/CP202787. Int J Clin Pharmacol Ther. 2017. PMID: 28157070

10

Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma.

Liu PH, Hsia CY, Lee YH, Hsu CY, Huang YH, Su CW, Lee RC, Lin HC, Huo TI. Liu PH, et al. J Surg Oncol. 2015 Mar 15;111(4):404-9. doi: 10.1002/jso.23854. Epub 2015 Feb 2. J Surg Oncol. 2015. PMID: 25643842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

173 results

Results by year